Select Medical (SEM) Form 4: 1,266-share grant at $14.22 to director

Q: What did SEM disclose in this Form 4 filing?

A director received 1,266 shares of restricted common stock on 10/28/2025 at $14.22 per share as part of director compensation.

Q: How many SEM shares does the reporting person own after the transaction?

Beneficial ownership is 304,063 shares following the reported transaction, held directly.

Q: Why was the restricted stock granted by SEM?

It was granted in lieu of a $18,000 quarterly retainer under the 2020 Equity Incentive Plan.

Q: What is the role of the reporting person at SEM?

The reporting person is a Director of Select Medical Holdings Corporation.

Q: What type of security was reported in the transaction?

The filing reports restricted common stock granted to the director.

Q: Was this a direct or indirect ownership at SEM?

Ownership following the grant is listed as Direct (D).

Select Medical Holdings (SEM) reported an insider equity transaction.

Accepted by SEC EDGAR 10/30/2025 - 05:24 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Select Medical Holdings (SEM) reported an insider equity transaction. A director received 1,266 shares of common stock on 10/28/2025 at a price of $14.22 per share. Following the grant, the reporting person beneficially owned 304,063 shares, held directly.

The filing states this was a restricted stock grant under the 2020 Equity Incentive Plan, issued in lieu of a quarterly cash retainer of $18,000. This reflects routine director compensation in stock rather than cash.

Insider Trade Summary

Grant/Award: 1,266 shares

Grant/Award 1 txn

Insider Frist William H.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,266	$14.22	$18K

Holdings After Transaction: Common Stock — 304,063 shares (Direct)

Footnotes (1)

F1. This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SEM disclose in this Form 4 filing?

A director received 1,266 shares of restricted common stock on 10/28/2025 at $14.22 per share as part of director compensation.

How many SEM shares does the reporting person own after the transaction?

Beneficial ownership is 304,063 shares following the reported transaction, held directly.

Why was the restricted stock granted by SEM?

It was granted in lieu of a $18,000 quarterly retainer under the 2020 Equity Incentive Plan.

What is the role of the reporting person at SEM?

The reporting person is a Director of Select Medical Holdings Corporation.

What type of security was reported in the transaction?

The filing reports restricted common stock granted to the director.

Was this a direct or indirect ownership at SEM?

Ownership following the grant is listed as Direct (D).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Frist William H.

(Last)

(First)

(Middle)

C/O SELECT MEDICAL HOLDINGS CORPORATION

4714 GETTYSBURG ROAD

(Street)

MECHANICSBURG

17055

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
SELECT MEDICAL HOLDINGS CORP [ SEM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/28/2025		A⁽¹⁾		1,266	A	$14.22	304,063	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000.

	/s/ John F. Duggan, Attorney-in-Fact	10/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR